506365 Stock Overview
Chemo Pharma Laboratories Limited does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Chemo Pharma Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹82.50 |
| 52 Week High | ₹87.00 |
| 52 Week Low | ₹27.17 |
| Beta | 0.22 |
| 1 Month Change | 50.00% |
| 3 Month Change | 10.00% |
| 1 Year Change | 112.08% |
| 3 Year Change | 224.17% |
| 5 Year Change | 806.59% |
| Change since IPO | 65.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506365 | IN Diversified Financial | IN Market | |
|---|---|---|---|
| 7D | 3.4% | -3.1% | -2.5% |
| 1Y | 112.1% | 74.1% | 44.5% |
Return vs Industry: 506365 exceeded the Indian Diversified Financial industry which returned 74.1% over the past year.
Return vs Market: 506365 exceeded the Indian Market which returned 44.5% over the past year.
Price Volatility
| 506365 volatility | |
|---|---|
| 506365 Average Weekly Movement | 7.5% |
| Diversified Financial Industry Average Movement | 7.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 506365's share price has been volatile over the past 3 months.
Volatility Over Time: 506365's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1942 | n/a | Bhavin Sheth | www.thechemopharmalaboratoriesltd.com |
Chemo Pharma Laboratories Limited does not have significant operations. Previously, the company was engaged in the finance and investment activities. Chemo Pharma Laboratories Limited was incorporated in 1942 and is based in Mumbai, India.
Chemo Pharma Laboratories Limited Fundamentals Summary
| 506365 fundamental statistics | |
|---|---|
| Market cap | ₹124.35m |
| Earnings (TTM) | ₹13.44m |
| Revenue (TTM) | ₹14.93m |
9.2x
P/E Ratio8.3x
P/S RatioIs 506365 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506365 income statement (TTM) | |
|---|---|
| Revenue | ₹14.93m |
| Cost of Revenue | ₹5.20k |
| Gross Profit | ₹14.92m |
| Other Expenses | ₹1.48m |
| Earnings | ₹13.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 8.96 |
| Gross Margin | 99.97% |
| Net Profit Margin | 90.03% |
| Debt/Equity Ratio | 0% |
How did 506365 perform over the long term?
See historical performance and comparison